Ph1/1b Study of WTX-124 Mono or + Pembro in Select Solid Tumors
Phase I/II Clinical Trial
A Multicenter Phase I/Ib Dose Escalation Study of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Patients with Selected Advanced or Metastatic Solid Tumors (WTX-124x2101)